CSV & Validation

What Is a Validation Master Plan? Requirements and Best Practice

7 min read By Mohammad Awawdeh

The Validation Master Plan (VMP) is the governing document for all validation activities at a pharmaceutical site. It establishes policy, defines scope, assigns responsibilities, and provides an overview of the validation programme. Regulators review it at the start of inspections to understand your approach - and gaps in the VMP signal gaps in the programme.

Regulatory Basis

EU GMP Annex 15 requires a written Validation Master Plan that describes the validation work to be performed. FDA expectations for equivalent documentation are covered in 21 CFR 211.68 and guidance documents including the Process Validation Guidance (2011). ICH Q10 supports the VMP as a key element of the pharmaceutical quality system.

What a VMP Must Contain

A well-structured VMP covers the following sections:

1. Validation Policy and Scope

Define what the organisation considers in-scope for validation: equipment, utilities, facilities, manufacturing processes, cleaning, analytical methods, and computerised systems. Define the risk-based approach used to determine validation requirements and depth.

2. Organisational Responsibilities

Name the roles responsible for initiating, conducting, reviewing, and approving validation activities. Define the interaction between validation, QA, engineering, manufacturing, IT, and regulatory affairs. Include a RACI matrix if helpful.

3. Regulatory Framework

Reference the applicable regulations and guidelines - FDA 21 CFR Parts 210/211, EU GMP Annex 11 and 15, ICH Q10, ISPE GAMP 5, and any product-specific guidelines. State the site's regulatory registration and inspection history context.

4. Equipment, System, and Process Inventory

Provide an inventory or reference to an inventory of all equipment, utilities, computerised systems, processes, and analytical methods within the validation scope. Include current qualification/validation status and scheduled review dates.

Practical tip: Keep the VMP itself concise - 15–30 pages. Reference detailed procedures (SOPs, protocols) rather than including them in the VMP. The VMP is the roadmap; the protocols are the journey. Inspectors expect the VMP to be readable and navigable.

5. Validation Approaches by Category

Describe the approach for each validation category:

  • Equipment/Utility Qualification - IQ, OQ, PQ structure, re-qualification criteria
  • Process Validation - Stage 1 (Process Design), Stage 2 (Process Qualification), Stage 3 (Continued Verification)
  • Cleaning Validation - approach, acceptance criteria basis (MACO), worst-case rationale
  • Analytical Method Validation - reference to ICH Q2(R2)
  • Computer System Validation - reference to CSV policy, GAMP 5 category approach

6. Change Control Integration

Describe how changes to validated systems, processes, and equipment trigger re-validation assessment. Reference the change control SOP and explain how change impact assessment links to the VMP.

7. Validation Schedule

Include a summary validation schedule or reference the current validation schedule document. Show planned validation activities for the next 12–24 months with responsible parties and target completion dates.

Common VMP Gaps Found in Inspections

  • VMP is outdated and does not reflect current site activities or systems
  • Scope does not include computerised systems or cleaning validation
  • Responsibilities are vague or reference roles that no longer exist
  • No validation schedule or the schedule has not been maintained
  • Risk-based approach is described but not actually applied in practice

VMP Review and Maintenance

Review the VMP annually as a minimum. Update it when significant changes occur: new facilities, new regulatory requirements, major product or process changes, or significant updates to the validation programme. Every approved version should be archived with a clear revision history explaining what changed and why.

PHARPRO - Expert Pharma Consulting

Need a Validation Master Plan that will hold up under regulatory scrutiny? PHARPRO prepares VMP documents as part of structured CSV engagements for pharmaceutical companies.

CSV & Validation Master Plan → Free Assessment
Related Insights

Keep reading

More in-depth guides from the PHARPRO compliance team.

Risk Assessment in CSV: Applying GAMP 5 Principles
How to conduct a risk assessment for computerised systems and document it to regulatory standards.
IQ OQ PQ Explained: What Each Phase Requires
Regulatory basis, documentation requirements, and what auditors look for in each qualification phase.
How to Write a URS for a Pharmaceutical Computerised System
Structure, GxP requirements, and a step-by-step guide to a compliant User Requirements Specification.
GAMP 5 Risk Categories Explained
What changed in the Second Edition, how to classify your system, and how category affects testing depth.
CSV for SaaS and Cloud Applications in Pharma
Validation approach, vendor qualification, and documentation strategy for cloud-hosted GxP systems.

Ready to strengthen your compliance programme?

Start with a free assessment - no commitment required.

Book Free Assessment WhatsApp